Literature DB >> 7183459

[The ajmaline test in identifying patients at high risk of developing complete paroxysmal atrioventricular block].

A Puglisi, R Ricci, G Angrisani.   

Abstract

In thirty-one patients (pts) with atrioventricular or intraventricular conduction disturbances, the Ajmaline test was used to evaluate the risk of evolution to complete atrioventricular block. Three groups of patients were identified: A = nine patients without history of syncope or dizziness; B = seventeen pts with history of syncope or dizziness but without evidence of complete atrioventricular block; C = five pts with recorded atrioventricular block and history of syncope or dizziness. All patients with symptoms (B-C groups) and with a positive Ajmaline test (i.e. HV greater than or equal to 90 msec.) were paced with regression of symptoms. All patients without symptoms (A group) and with a positive Ajmaline test (i.e. HV greater than or equal to 90 msec.) were not paced and did not progress to complete atrioventricular block in a follow-up period of two years. Our results confirm that the Ajmaline test is useful in demonstrating the cardiac origin of syncopal episodes, but an HV value of 90 msec, does not seem to be specific enough in identifying asymptomatic patients at risk of developing complete atrioventricular block.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7183459

Source DB:  PubMed          Journal:  G Ital Cardiol        ISSN: 0046-5968


  1 in total

1.  Ajmaline Challenge To Unmask Infrahisian Disease In Patients With Recurrent And Unexplained Syncope, Preserved Ejection Fraction, With Or Without Conduction Abnormalities On Surface ECG.

Authors:  Francesco Pentimalli; Luca Bacino; Matteo Ghione; Siri Giambattista; Massimo Gazzarata; Paolo Bellotti
Journal:  J Atr Fibrillation       Date:  2016-08-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.